European Medicines Agency - Regulatory - Regulation of medicines

D - Description



  Description

Name

JSWG of PRES - Juvenile Scleroderma Working Group of the Pediatric Rheumatology European Society

Year of foundation 2003
Preterm and/or term newborn No
Infants from 1 month to less than 24 months of age Yes
Children from 2 years to less than 12 years of age Yes
Adolescents from 12 years to less than 18 years Yes
Paediatric age ranges of study participants covered by the network 0-18 years
Multispeciality? Specify no
Speciality/disease specific? Specify pediatric rheumatology
Conditions covered? Specify juvenile scleroderma- localised and systemic
Procedure/Intervention specific? Specify observational studies
Number of collaborating countries 0
List of collaborating countries all EU countries, and Russia, Brazil, Argentina and USA
Number of collaborating centres 50
List of collaborating centres see attached list
Type of activity/studies
Clinical Studies Yes
Experimental research No
Other activity educational programms